See more : Chenghe Acquisition II Co. (CHEB) Income Statement Analysis – Financial Results
Complete financial analysis of Trellus Health plc (TRLS.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Trellus Health plc, a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Priority Income Fund, Inc. (PRIF-PF) Income Statement Analysis – Financial Results
- Crystal Clear Electronic Material Co.,Ltd (300655.SZ) Income Statement Analysis – Financial Results
- AusCann Group Holdings Ltd (ACNNF) Income Statement Analysis – Financial Results
- Omnia Holdings Limited (OMN.JO) Income Statement Analysis – Financial Results
- Yakult Honsha Co.,Ltd. (2267.T) Income Statement Analysis – Financial Results
Trellus Health plc (TRLS.L)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.trellushealth.com
About Trellus Health plc
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers TrellusElevate, a proprietary HIPAA-compliant technology platform to coordinate and deliver personalized care remotely through telemedicine. Its platform provides patients with access to a care team, educational content resources, and remote monitoring capabilities for the treatment of inflammatory bowel diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The company was founded in 2020 and is headquartered in White Plains, New York.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 19.00K | 18.00K | 25.00K | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 19.00K | 18.00K | 25.00K | 0.00 |
| Gross Profit Ratio | 100.00% | 100.00% | 100.00% | 0.00% |
| Research & Development | 0.00 | 593.00K | 22.00K | 0.00 |
| General & Administrative | 1.96M | 8.83M | 5.93M | 474.00K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 1.05M |
| SG&A | 1.96M | 8.83M | 5.93M | 1.52M |
| Other Expenses | 4.86M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 6.82M | 8.83M | 5.93M | 1.52M |
| Cost & Expenses | 6.82M | 8.83M | 5.93M | 1.52M |
| Interest Income | 464.00K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 716.00K | 536.00K | 32.00K | 2.00K |
| EBITDA | -5.85M | -8.27M | -5.87M | -1.52M |
| EBITDA Ratio | -30,768.42% | -45,966.67% | -23,480.00% | 0.00% |
| Operating Income | -6.80M | -8.81M | -5.90M | -1.52M |
| Operating Income Ratio | -35,805.26% | -48,944.44% | -23,608.00% | 0.00% |
| Total Other Income/Expenses | 464.00K | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -6.34M | -8.81M | -5.90M | -1.52M |
| Income Before Tax Ratio | -33,363.16% | -48,944.44% | -23,608.00% | 0.00% |
| Income Tax Expense | 0.00 | -123.00K | -204.56K | 0.00 |
| Net Income | -6.34M | -8.81M | -5.90M | -1.52M |
| Net Income Ratio | -33,363.16% | -48,944.44% | -23,608.00% | 0.00% |
| EPS | -0.04 | -0.05 | -0.04 | -0.02 |
| EPS Diluted | -0.04 | -0.05 | -0.04 | -0.02 |
| Weighted Avg Shares Out | 161.51M | 161.51M | 131.73M | 84.04M |
| Weighted Avg Shares Out (Dil) | 161.51M | 161.51M | 131.73M | 84.04M |
Source: https://incomestatements.info
Category: Stock Reports